HUMA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Humacyte Inc (HUMA).


$635.59M Market Cap.

As of 04/02/2025 5:00 PM ET (MRY) • Disclaimer

HUMA Market Cap. (MRY)


HUMA Shares Outstanding (MRY)


HUMA Assets (MRY)


Total Assets

$137.87M

Total Liabilities

$190.54M

Total Investments

$0

HUMA Income (MRY)


Revenue

$0

Net Income

-$148.70M

Operating Expense

$114.40M

HUMA Cash Flow (MRY)


CF Operations

-$98.12M

CF Investing

-$1.57M

CF Financing

$114.18M

HUMA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

HUMA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$137,872,000 (7.53%)

$128,223,000 (-37.24%)

$204,302,000 (-28.70%)

$286,533,000 (168.57%)

Assets Current

$47,859,000 (-42.53%)

$83,278,000 (-46.00%)

$154,208,000 (-32.76%)

$229,340,000 (453.31%)

Assets Non-Current

$90,013,000 (100.27%)

$44,945,000 (-10.28%)

$50,094,000 (-12.41%)

$57,193,000 (-12.33%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$52,669,000 (-488.82%)

$13,546,000 (-88.42%)

$116,928,000 (-4.29%)

$122,174,000 (134.88%)

Property Plant & Equipment Net

$38,553,000 (-12.59%)

$44,104,000 (-10.74%)

$49,412,000 (-13.60%)

$57,193,000 (-12.33%)

Cash & Equivalents

$95,146,000 (18.27%)

$80,448,000 (-46.29%)

$149,772,000 (-31.14%)

$217,502,000 (444.72%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$2,107,000 (-73.66%)

$8,000,000 (0%)

Investments Current

$0 (0%)

$0 (0%)

$2,107,000 (-73.66%)

$8,000,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$31,000 (-82.39%)

$176,000 (55.75%)

Trade & Non-Trade Payables

$4,490,000 (-30.82%)

$6,490,000 (306.90%)

$1,595,000 (-23.83%)

$2,094,000 (-7.92%)

Accumulated Retained Earnings (Deficit)

-$686,015,000 (-27.67%)

-$537,314,000 (-25.97%)

-$426,538,000 (-2.89%)

-$414,573,000 (-6.82%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$173,000 (-40.14%)

Total Debt

$79,891,000 (38.93%)

$57,506,000 (14.86%)

$50,066,000 (-2.17%)

$51,178,000 (77.33%)

Debt Current

$2,917,000 (11.63%)

$2,613,000 (-75.98%)

$10,877,000 (436.87%)

$2,026,000 (-52.01%)

Debt Non-Current

$76,974,000 (40.23%)

$54,893,000 (40.07%)

$39,189,000 (-20.27%)

$49,152,000 (99.49%)

Total Liabilities

$190,541,000 (66.15%)

$114,677,000 (31.25%)

$87,374,000 (-46.84%)

$164,359,000 (356.35%)

Liabilities Current

$19,954,000 (8.19%)

$18,443,000 (-5.81%)

$19,580,000 (77.19%)

$11,050,000 (-1.63%)

Liabilities Non-Current

$170,587,000 (77.26%)

$96,234,000 (41.95%)

$67,794,000 (-55.78%)

$153,309,000 (518.61%)

HUMA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$1,565,000 (23.91%)

$1,263,000 (-15.29%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$25,799,000 (9.80%)

$23,497,000 (2.68%)

$22,883,000 (8.30%)

$21,130,000 (75.89%)

Research & Development Expense

$88,599,000 (15.74%)

$76,550,000 (21.01%)

$63,260,000 (3.13%)

$61,341,000 (13.43%)

Operating Expenses

$114,398,000 (14.34%)

$100,047,000 (16.14%)

$86,143,000 (4.45%)

$82,471,000 (24.78%)

Interest Expense

$9,277,000 (40.58%)

$6,599,000 (6.44%)

$6,200,000 (42.59%)

$4,348,000 (97.46%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$148,701,000 (-34.24%)

-$110,776,000 (-825.83%)

-$11,965,000 (54.81%)

-$26,477,000 (60.20%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$148,701,000 (-34.24%)

-$110,776,000 (-825.83%)

-$11,965,000 (54.81%)

-$26,477,000 (60.20%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$148,701,000 (-34.24%)

-$110,776,000 (-825.83%)

-$11,965,000 (54.81%)

-$26,477,000 (60.20%)

Weighted Average Shares

$118,479,097 (14.56%)

$103,420,238 (0.36%)

$103,051,366 (157.82%)

$39,970,398 (593.25%)

Weighted Average Shares Diluted

$118,479,097 (14.56%)

$103,420,238 (0.36%)

$103,051,366 (157.82%)

$39,970,398 (593.25%)

Earning Before Interest & Taxes (EBIT)

-$139,424,000 (-33.83%)

-$104,177,000 (-1707.06%)

-$5,765,000 (73.95%)

-$22,129,000 (65.60%)

Gross Profit

$0 (0%)

$0 (0%)

$1,565,000 (23.91%)

$1,263,000 (-15.29%)

Operating Income

-$114,398,000 (-14.34%)

-$100,047,000 (-18.29%)

-$84,578,000 (-4.15%)

-$81,208,000 (-25.71%)

HUMA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,572,000 (-808.67%)

-$173,000 (-103.57%)

$4,845,000 (158.94%)

-$8,220,000 (-2967.16%)

Net Cash Flow from Financing

$114,183,000 (2433.46%)

$4,507,000 (411.69%)

-$1,446,000 (-100.54%)

$266,983,000 (12910.87%)

Net Cash Flow from Operations

-$98,122,000 (-33.85%)

-$73,305,000 (-3.06%)

-$71,129,000 (12.39%)

-$81,190,000 (-46.11%)

Net Cash Flow / Change in Cash & Cash Equivalents

$14,489,000 (121.01%)

-$68,971,000 (-1.83%)

-$67,730,000 (-138.14%)

$177,573,000 (430.16%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$2,107,000 (-64.25%)

$5,893,000 (173.66%)

-$8,000,000 (0%)

Capital Expenditure

-$1,572,000 (31.05%)

-$2,280,000 (-117.56%)

-$1,048,000 (-376.36%)

-$220,000 (17.91%)

Issuance (Repayment) of Debt Securities

$16,921,000 (305.68%)

$4,171,000 (310.55%)

-$1,981,000 (-107.09%)

$27,930,000 (1495.09%)

Issuance (Purchase) of Equity Shares

$97,022,000 (17041.70%)

$566,000 (5.79%)

$535,000 (-99.78%)

$242,998,000 (80630.23%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,137,000 (-10.12%)

$6,828,000 (10.41%)

$6,184,000 (-39.05%)

$10,146,000 (116.15%)

Depreciation Amortization & Accretion

$7,243,000 (-6.77%)

$7,769,000 (-5.89%)

$8,255,000 (-0.34%)

$8,283,000 (-1.77%)

HUMA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-

-764.50% (63.53%)

-2096.40% (53.01%)

EBITDA Margin

-

-

159.10% (114.51%)

-1096.30% (70.75%)

Return on Average Equity (ROAE)

501.80% (319.22%)

-228.90% (-2212.12%)

-9.90% (-151.03%)

19.40% (-6.73%)

Return on Average Assets (ROAA)

-107.70% (-52.77%)

-70.50% (-1282.35%)

-5.10% (61.65%)

-13.30% (72.46%)

Return on Sales (ROS)

-

-

-368.40% (78.97%)

-1752.10% (59.39%)

Return on Invested Capital (ROIC)

-133.30% (-14.13%)

-116.80% (-1879.66%)

-5.90% (74.46%)

-23.10% (68.44%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.01 (-51.02%)

-2.65 (84.91%)

-17.58 (-60.06%)

-10.98 (-1146.88%)

Price to Sales Ratio (P/S)

-

-

138.94 (-39.45%)

229.44 (483.42%)

Price to Book Ratio (P/B)

-12.07 (-155.57%)

21.71 (1066.85%)

1.86 (-69.55%)

6.11 (1738.61%)

Debt to Equity Ratio (D/E)

-3.62 (-142.74%)

8.47 (1033.33%)

0.75 (-44.46%)

1.34 (1405.83%)

Earnings Per Share (EPS)

-1.26 (-17.76%)

-1.07 (-791.67%)

-0.12 (81.82%)

-0.66 (94.28%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0.01 (-53.13%)

0.03 (-87.64%)

Free Cash Flow Per Share (FCFPS)

-0.84 (-15.05%)

-0.73 (-4.43%)

-0.7 (65.64%)

-2.04 (78.97%)

Book Value Per Share (BVPS)

-0.45 (-439.69%)

0.13 (-88.46%)

1.14 (-62.87%)

3.06 (105.03%)

Tangible Assets Book Value Per Share (TABVPS)

1.16 (-6.13%)

1.24 (-37.47%)

1.98 (-72.34%)

7.17 (-61.26%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-150.00%)

-2 (88.89%)

-18 (28.00%)

-25 (-1150.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.87 (-87.25%)

-2.6 (-106.19%)

42.06 (206.18%)

-39.62 (-1609.84%)

Asset Turnover

0 (0%)

0 (0%)

0.01 (16.67%)

0.01 (-45.45%)

Current Ratio

2.4 (-46.89%)

4.51 (-42.67%)

7.88 (-62.05%)

20.75 (462.47%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$99,694,000 (-31.90%)

-$75,585,000 (-4.72%)

-$72,177,000 (11.34%)

-$81,410,000 (-45.80%)

Enterprise Value (EV)

$644,194,455 (156.71%)

$250,946,727 (139.59%)

$104,740,953 (-80.91%)

$548,531,534 (323.55%)

Earnings Before Tax (EBT)

-$148,701,000 (-34.24%)

-$110,776,000 (-825.83%)

-$11,965,000 (54.81%)

-$26,477,000 (60.20%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$132,181,000 (-37.11%)

-$96,408,000 (-3971.81%)

$2,490,000 (117.98%)

-$13,846,000 (75.23%)

Invested Capital

$102,663,000 (18.22%)

$86,838,000 (2.14%)

$85,016,000 (-22.12%)

$109,159,000 (29.36%)

Working Capital

$27,905,000 (-56.96%)

$64,835,000 (-51.84%)

$134,628,000 (-38.33%)

$218,290,000 (622.43%)

Tangible Asset Value

$137,872,000 (7.53%)

$128,223,000 (-37.24%)

$204,302,000 (-28.70%)

$286,533,000 (168.57%)

Market Capitalization

$635,590,455 (116.07%)

$294,153,727 (35.19%)

$217,579,953 (-70.86%)

$746,774,534 (471.21%)

Average Equity

-$29,631,250 (-161.24%)

$48,385,750 (-59.83%)

$120,437,500 (188.03%)

-$136,812,750 (57.19%)

Average Assets

$138,095,750 (-12.14%)

$157,172,500 (-33.21%)

$235,338,500 (18.08%)

$199,301,500 (44.75%)

Invested Capital Average

$104,613,500 (17.33%)

$89,158,250 (-9.09%)

$98,074,500 (2.26%)

$95,910,250 (9.15%)

Shares

125,859,496 (21.52%)

103,575,256 (0.44%)

103,118,461 (0.11%)

103,003,384 (701.27%)